Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue Suppl 1
22 New and approved therapies for SLE: Anifrolumab
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Abstracts
Prime time session: treatment targets and novel therapies
22 New and approved therapies for SLE: Anifrolumab
Online download statistics by month:
Online download statistics by month: April 2022 to September 2024
Abstract
Full
Pdf
Apr 2022
113
0
28
May 2022
23
0
11
Jun 2022
18
0
6
Jul 2022
29
0
0
Aug 2022
26
0
2
Sep 2022
10
0
2
Oct 2022
8
0
2
Nov 2022
23
0
6
Dec 2022
25
0
2
Jan 2023
18
0
0
Feb 2023
14
0
9
Mar 2023
11
0
2
Apr 2023
8
0
3
May 2023
1
0
1
Jun 2023
2
0
0
Jul 2023
6
0
2
Aug 2023
6
0
1
Sep 2023
4
0
2
Oct 2023
5
0
2
Nov 2023
19
0
1
Dec 2023
4
0
3
Jan 2024
16
0
1
Feb 2024
14
0
1
Mar 2024
6
0
0
Apr 2024
8
0
1
May 2024
13
0
4
Jun 2024
14
0
3
Jul 2024
9
0
6
Aug 2024
2
0
4
Sep 2024
20
0
1
Total
475
0
106
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?